The Novartis Access has extended portfolio of high-quality medicines targeted at four key non-communicable diseases (NCDs) to the sixth country on the continent of Africa while Nigeria still aloof, reports NaijaAgroNet.
The latest addition being the Republic of Cameroon, just as NaijaAgroNet reports that Novartis Access had landed at Kenya, Ethiopia, Rwanda, Pakistan and Uganda before now.
According to Novartis Global Media Relations, Eric Althoff they were pleased to disclosed this in partnership with the Ministry of Public Health of Cameroon after they signed a Memorandum of Understanding (MoU) to implement Novartis Access in Cameroon.
The collaboration, NaijaAgroNet also reports include capacity-building activities with the Cameroon Baptist Convention Health Services (CBCHS) on community awareness. Initially.
Althoff said, Novartis Access medicines will be made available through CBCHS hospitals and clinics, with the objective to extend the programme to other faith-based organizations across the country.
Novartis Access, NaijaAgroNet gathered, provides a portfolio of high-quality medicines targeting four key non-communicable diseases (NCDs), namely, cardiovascular diseases, diabetes, respiratory illnesses, and breast cancer. This portfolio covers the world’s most frequently prescribed medicines for chronic diseases.
“Cameroon is increasingly affected by the burden of noncommunicable diseases,” said André Mama Fouda, Minister of Public Health of the Republic of Cameroon. “The government has established prevention and control programs for chronic diseases, and having access to high-quality treatments at low cost is critical to success. This collaboration with Novartis is part of the solution.”
According to the WHO, chronic diseases cause 31% (1) of all deaths every year in Cameroon, and a survey by the CBCHS showed consultations for NCDs at some of their health facilities rose by over 40% between 2011 and 2015 (2).
“We are pleased to help Cameroonian patients better manage their chronic conditions,” said Dr. Harald Nusser, Head of Novartis Social Business. “We believe new approaches such as Novartis Access that bring governments, the private sector and social sector together are needed to expand access to medicines and healthcare delivery.”
Beyond medicines, the collaboration will also offer activities to strengthen healthcare systems in Cameroon, for example by training healthcare professionals on NCD screening, diagnosis and treatment, quality assurance and by providing community education and awareness.
“This month, CBCHS and Novartis will kick off a Know Your Numbers campaign to encourage individuals to know their vital health numbers through community awareness and screenings,” said Prof. Tih Pius Muffih, Director of CBCHS. “Activities such as this campaign are needed to ensure we combat NCDs effectively, thanks to stronger healthcare systems and high-quality medicines.”
The campaign will take place in seven health districts in five regions, reaching a potential population of 1 million people with education and NCD health checks.
Isaac Oyimah/GEE... Linking agrobiz, sustainable environs, people & technology